Karen Reeves
Corporate Officer/Principal bei LIGAND PHARMACEUTICALS INCORPORATED
Aktive Positionen von Karen Reeves
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 20.02.2024 | - |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 | - |
| Präsident | 01.09.2017 | - |
Karriereverlauf von Karen Reeves
Ehemalige bekannte Positionen von Karen Reeves
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KIROMIC BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 14.02.2022 | 06.12.2022 |
| Independent Dir/Board Member | 14.02.2022 | 06.12.2022 | |
| MEDIVATION INC | Corporate Officer/Principal | 18.12.2009 | 29.03.2010 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Karen Reeves
| Yale University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Karen Reeves
- Erfahrung
